EXPRESS: Novel composite clinical endpoints and risk scores used in clinical trials in PAH

This manuscript on endpoints incorporates the broad experience of members of Pulmonary Vascular Research Institute’s Innovative Drug Development Initiative as an open debate platform for academia, ...